Company Overview of Hamilton Pharmaceuticals, Inc.
Hamilton Pharmaceuticals, Inc. develops and commercializes medical treatments for central nervous system disease. The company’s investigational compound targets disabling psychiatric sequellae of stroke and brain disorders. The company was founded in 2004 and is based in Washington, District of Columbia. As of October 16, 2007, Hamilton Pharmaceuticals, Inc. operates as a subsidiary of Neuren Pharmaceuticals Limited.
1825 K Street N.W.
Washington, DC 20006
Founded in 2004
Key Executives for Hamilton Pharmaceuticals, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Hamilton Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.